Arovella Therapeutics Limited (ASX: ALA)

Arovella Therapeutics Revenue

In the fiscal year ending June 30, 2024, Arovella Therapeutics had annual revenue of 1.95M AUD with 34.20% growth. Arovella Therapeutics had revenue of 8.50K in the half year ending June 30, 2024, a decrease of -96.89%.

• Revenue: 1.95M
• Revenue Growth: +34.20%
• P/S Ratio: 86.83
• Revenue / Employee: 72.30K
• Employees: 27
• Market Cap: 189.66M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	1.95M	497.46K	34.20%
Jun 30, 2023	1.45M	1.16M	391.76%
Jun 30, 2022	295.81K	-693.91K	-70.11%
Jun 30, 2021	989.72K	-261.71K	-20.91%
Jun 30, 2020	1.25M	644.00	0.05%